Breadcrumb Home News Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment Twin Cities patients must travel for monoclonal antibodies COVID-19 treatment September 29, 2021 JP Leider, PhD comments on privilege and fairness regarding access to the increasingly in-demand treatment. Previous News UnitedHealth Group, University of Minnesota Partner to Launch Course on Value-Based Care What Gives You Hope For Health Equity? Using Data to Connect People: Why We Are Unveiling a New Geospatial Dashboard Tool to Help Analyze Public Health Workforce Supply Across the U.S.